Enhancement of in vitro cholesterol-lowering and anti-diabetic activities of gluten hydrolysate prepared using kiwifruit protease as affected by ultrasound and atmospheric cold plasma post-treatments

Babak Mousavi,Soottawat Benjakul,Ghasem Hassani,Safoora Pashangeh,Sajad Ghaderi
DOI: https://doi.org/10.1007/s11694-023-02118-w
2023-09-03
Abstract:Protein hydrolysates from soft and hard wheat gluten were prepared using kiwifruit protease, followed by post-treatments using ultrasound (US) and atmospheric cold plasma (ACP). Peptides with different molecular weights (Mw) were determined for in vitro physicochemical and biological properties. US and ACP-treated peptides with molecular weight (Mw) of 451–1002 Da and > 12,400 Da constituted by 63–65% and 36–39%, respectively. The content of free SH groups in US and ACP treated peptides increased and decreased, respectively, while the S–S content was not altered. The surface hydrophobicity of hydrolysate increased with treatment intensity and time. The selected fraction with the smallest Mw namely HGH-U25 (< 1 kDa) exhibited the highest inhibitory activity toward α-glucosidase (14.25 ± 0.11%), and α-amylase (37.56 ± 1.12%). SGH-CP60/30 (10 − 100 kDa) showed the strongest cholesterol-lowering activity (47.08 ± 1.71%). High levels of hydrophobic amino acids and proline in S2 (40.91%, 10.88%) and P3 (54.11%, 29.11%) respectively, were more likely related with α-glucosidase (22.17%) and α-amylase inhibition (37.16%) and cholesterol-lowering (55.26%) activity. Thus, new hydrolysates derived from gluten with in vitro cholesterol-lowering activity could act as an anti-diabetic agent.
food science & technology
What problem does this paper attempt to address?